Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This target is a **pseudogene** corresponding to the protein coding gene *mannosidase alpha class 1B member 1* (MAN1B1). Pseudogenes are genomic sequences similar to known genes that have lost their ability to encode a functional protein, mostly due to mutations or lack of regulatory elements[4][2]. The MAN1B1 *protein coding* gene is an enzyme involved in N-glycan biosynthesis and ER protein quality control, whose mutations can cause certain congenital diseases[1][3]. However, the ENSG00000254725 entry is for a related pseudogene — it is not transcribed or translated into a functional enzyme and has no therapeutic or biological relevance as a target[5][4].
None (as above, no active protein product, thus no mechanism of action for drugs)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mannosidase, alpha, class 1B, member 1 pseudogene (MAN1B1 pseudogene (no universally accepted abbreviation; MAN1B1 is used for the functional gene)).